Summit Trail Advisors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$196K Sell
13,090
-1,004
-7% -$14.7K ﹤0.01% 1378
2025
Q4
$188K Hold
14,094
﹤0.01% 1275
2025
Q3
$222K Hold
14,094
﹤0.01% 1273
2025
Q2
$212K Hold
14,094
﹤0.01% 1039
2025
Q1
$212K Buy
14,094
+1,004
+8% +$14.8K 0.01% 371
2024
Q4
$189K Buy
13,090
+1,647
+14% +$29.4K 0.01% 362
2024
Q3
$223K Buy
+11,443
New +$207K 0.01% 647

Other funds holding HCM

Summit Trail Advisors's HCM Position: Q1 2026 in Review

Summit Trail Advisors reduced its HUTCHMED (HCM) stake by 7.1% in Q1 2026, selling an estimated $14.7K and leaving 13,090 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Summit Trail Advisors first reported a position in HCM in Q3 2024 and has held it in 7 quarters since. The position peaked at $223K in Q3 2024. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Summit Trail Advisors held 13,090 shares of HUTCHMED worth $196K as of Q1 2026.
  • Summit Trail Advisors sold 1,004 HUTCHMED shares in Q1 2026, an estimated $14.7K.
  • HUTCHMED made up ﹤0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #1378 holding.
  • Summit Trail Advisors first reported a position in HUTCHMED in Q3 2024 and has held it in 7 quarters since.
  • Summit Trail Advisors's HUTCHMED position peaked at $223K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.